Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-100065
Filing Date
2024-08-23
Accepted
2024-08-23 11:56:46
Documents
17
Period of Report
2024-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A rkda-20240702.htm   iXBRL 8-K/A 51705
2 EX-10.1 rkda-ex10_1.htm EX-10.1 231643
3 EX-10.2 rkda-ex10_2.htm EX-10.2 222035
4 GRAPHIC img5370606_0.jpg GRAPHIC 68051
5 GRAPHIC img5370606_1.jpg GRAPHIC 16944
6 GRAPHIC img6294127_0.jpg GRAPHIC 68051
7 GRAPHIC img6294127_1.jpg GRAPHIC 16944
  Complete submission text file 0000950170-24-100065.txt   915064

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20240702.xsd EX-101.SCH 25774
19 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20240702_htm.xml XML 5406
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37383 | Film No.: 241234879
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)